A detailed history of Capital International LTD transactions in Bio N Tech Se stock. As of the latest transaction made, Capital International LTD holds 24,688 shares of BNTX stock, worth $2.63 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
24,688
Previous 22,874 7.93%
Holding current value
$2.63 Million
Previous $2.11 Million 6.02%
% of portfolio
0.09%
Previous 0.11%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$80.36 - $102.87 $145,773 - $186,606
1,814 Added 7.93%
24,688 $1.98 Million
Q1 2024

May 14, 2024

BUY
$88.96 - $112.35 $160,839 - $203,128
1,808 Added 8.58%
22,874 $2.11 Million
Q4 2023

Feb 13, 2024

BUY
$90.91 - $112.75 $19,636 - $24,354
216 Added 1.04%
21,066 $2.22 Million
Q3 2023

Nov 13, 2023

SELL
$98.5 - $125.08 $26,299 - $33,396
-267 Reduced 1.26%
20,850 $2.27 Million
Q2 2023

Aug 11, 2023

BUY
$102.58 - $129.66 $267,015 - $337,504
2,603 Added 14.06%
21,117 $2.28 Million
Q1 2023

May 15, 2023

BUY
$122.57 - $153.67 $106,268 - $133,231
867 Added 4.91%
18,514 $2.31 Million
Q4 2022

Feb 14, 2023

BUY
$118.43 - $186.05 $188,658 - $296,377
1,593 Added 9.92%
17,647 $2.65 Million
Q3 2022

Nov 14, 2022

BUY
$127.65 - $183.11 $1.73 Million - $2.49 Million
13,578 Added 548.38%
16,054 $2.17 Million
Q2 2022

Aug 15, 2022

SELL
$123.25 - $186.24 $1.9 Million - $2.87 Million
-15,393 Reduced 86.14%
2,476 $369,000
Q1 2022

May 16, 2022

BUY
$126.25 - $231.85 $334,688 - $614,634
2,651 Added 17.42%
17,869 $3.05 Million
Q4 2021

Feb 14, 2022

BUY
$216.64 - $362.52 $924,619 - $1.55 Million
4,268 Added 38.98%
15,218 $3.92 Million
Q3 2021

Nov 15, 2021

SELL
$205.93 - $447.23 $1.02 Million - $2.21 Million
-4,947 Reduced 31.12%
10,950 $2.99 Million
Q2 2021

Aug 16, 2021

BUY
$113.32 - $241.49 $629,945 - $1.34 Million
5,559 Added 53.77%
15,897 $3.56 Million
Q1 2021

May 14, 2021

BUY
$85.73 - $119.5 $886,276 - $1.24 Million
10,338 New
10,338 $1.13 Million

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $25.9B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Capital International LTD Portfolio

Follow Capital International LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International LTD , based on Form 13F filings with the SEC.

News

Stay updated on Capital International LTD with notifications on news.